INVST’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
1,728
-954
-36% -$264K 0.04% 280
2026
Q1
$792K Sell
2,682
-108
-4% -$32.1K 0.09% 192
2025
Q4
$762K Sell
2,790
-122
-4% -$33.2K 0.08% 194
2025
Q3
$787K Sell
2,912
-51
-2% -$13.9K 0.09% 186
2025
Q2
$817K Sell
2,963
-116
-4% -$31.5K 0.1% 161
2025
Q1
$817K Buy
+3,079
New +$760K 0.11% 144
2020
Q1
Sell
-1,198
Closed -$240K 110
2019
Q4
$240K Buy
1,198
+4
+0.3% +$821 0.09% 75
2019
Q3
$252K Sell
1,194
-31
-3% -$6.48K 0.11% 68
2019
Q2
$241K Sell
1,225
-256
-17% -$47.2K 0.12% 53
2019
Q1
$247K Buy
1,481
+202
+16% +$35.7K 0.12% 52
2018
Q4
$241K Buy
1,279
+13
+1% +$2.4K 0.14% 41
2018
Q3
$221K Buy
+1,266
New +$213K 0.11% 45

Other funds holding CME

INVST's CME Position: Q2 2026 in Review

INVST reduced its CME Group (CME) stake by 36% in Q2 2026, selling an estimated $264K and leaving 1,728 shares worth $382K. The position accounts for 0.04% of the portfolio, ranked #280.

INVST first reported a position in CME in Q3 2018 and has held it in 12 quarters since. The position peaked at $817K in Q1 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • INVST held 1,728 shares of CME Group worth $382K as of Q2 2026.
  • INVST sold 954 CME Group shares in Q2 2026, an estimated $264K.
  • CME Group made up 0.04% of INVST's portfolio in Q2 2026, its #280 holding.
  • INVST first reported a position in CME Group in Q3 2018 and has held it in 12 quarters since.
  • INVST's CME Group position peaked at $817K in Q1 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.